2023-506003-26-00
招募中
1 期
A Phase 1 Study of BMS-986453 in Participants with Relapsed and/or Refractory Multiple Myeloma
概览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 19
- 试验地点
- 6
概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
GSM-CT
Scientific
Celgene Corp.
研究点 (6)
Loading locations...
相似试验
招募中
不适用
A Phase 1/2 Study of BMS-986340 in Participants with Advanced Solid Tumors (CA052002)jRCT2031240229Bristol-Myers Squibb665
已完成
2 期
Safety and Efficacy of BMS-986165 in Subjects with Moderate to Severe Ulcerative Colitis (IM011-024)jRCT2080224801Bristol-Myers Squibb120
已完成
2 期
Efficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid ArthritisjRCT2080223262Bristol-Myers Squibb K.K.408
招募中
1 期
A Phase 1 Study of BMS-986406 as Monotherapy and in Combination in Advanced Tumorsadvanced tumorsJPRN-jRCT2031230298Walker Justin154
进行中（未招募）
不适用
A Phase II Study of BMS-354825 in Subjects with Myeloid Blast Phase Chronic MyeloidLeukemia Resistant to or Intolerant of Imatinib MesylateRevised Protocol 01: Incorporates Amendment 03 and Administrative Letter dated 25-February-2005.Amendment 01 country specific version 1.0 dated 2005-03-14Myeloid Blast Phase Chronic Myeloid LeukemiaEUCTR2004-002516-28-BEBristol-Myers Squibb International Corporation256